More articles from Supplement

Conventional treatment and outcome of Wegener’s granulomatosis and microscopic polyangiitis
David R.W. Jayne, MD
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-110-SII-115;
Treating the Permanent Sequelae of Vasculitis
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-191-SII-192;
Analysis of Autoantibody Repertoires in Small and Medium Sized Vessel Vasculitis: Evidence for Disease-Specific Perturbations in Classic Polyarteritis Nodosa (PAN), Micropolyangiitis (MPA), Churg-Strauss Syndrome (CSS) and Wegener’s Granulomatosis (WG)
Y Chanseaud, L Guillevin, M Kambouchner, MC Boissier and L Mouthon
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
Kawasaki disease: Etiology, pathogenesis, and treatment
Karyl S. Barron, MD
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-69-SII-78;
Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in “Non-Renal” Anca-Associated Vasculitis
K de Groot, N Rasmussen, JW Cohen Tervaert, DRW Jayne and
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-116;
Author Index
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-193-SII-196;
Granuloma formation, implications for the pathogenesis of vasculitis
Michael C. Sneller, MD
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-40-SII-43;
Epidemiology of giant-cell arteritis
Gene G. Hunder, MD
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-79-SII-82;
Treatment of giant-cell arteritis: where we have been and why we must move on
Gary S. Hoffman, MD
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII117-SII120;
Chemokine Receptor Expression on CD4+ and CD8+ Memory T-Cells and in Granulomas in Wegener’s Granulomatosis
P Lamprecht, A Erdmann, A Mueller, E Csernok, H Bruehl, WL Gross and M Mack
Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;

Pages